Lannett Company, Inc.
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
Published in Medical Letter on the CDC and FDA, May 31st, 2009
Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its supplemental Abbreviated New Drug Application (ANDAs) for Pilocarpine HCI tablets, 7.5 mg, the generic equivalent of SalagenŽ, marketed by Eisai Pharmaceuticals. Lannett previously received and currently markets Pilocarpine HCI tablets, in the 5 mg strength. According to Wolters Kluwer, sales in 2008 of both generic and brand Pilocarpine HCI 7.5 mg tablets were $2.5 million at Average Wholesale Price.
Pilocarpine HCI tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- BioMed Central
Improving education may cut smoking in youth - UT Southwestern Medical Center
Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report - Addiction Medicine
Study data from University of Medicine and Dentistry of New Jersey update knowledge of addiction medicine - Arrhythmia
Weight-loss Supplements May Cause Life-threatening Cardiac Complications or Death - Colon Cancer
Researchers at Food & Drug Administration have published new data on colon cancer - Emergent BioSolutions Inc.
Emergent BioSolutions Launches BioThrax.com, an Educational Website about BioThrax Anthrax Vaccine Adsorbed and Anthrax Disease - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
